Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
Pharma
The Readout

Biotech rides the Trump train & Alexion’s November surprise

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Nov. 10, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for November 10, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Insurance alone didn’t guarantee adherence to Ozempic, study finds
Insurance alone didn’t guarantee adherence to Ozempic, study finds
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
New guidelines simplify cholesterol tests: no fasting needed
New guidelines simplify cholesterol tests: no fasting needed
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories